Trade Desk, Leidos, Devon Energy And A Major Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management named The Trade Desk, Inc. TTD as his final trade.

Trade Desk, meanwhile, will release its fourth-quarter financial results after the closing bell today. Analysts expect the Ventura, California-based company to report quarterly earnings at 57 cents per share, up from 41 cents per share in the year-ago period. Trade Desk projects quarterly revenue of $759.56 million, compared to $605.8 million a year earlier, according to data from Benzinga Pro.

Stephen Weiss of Short Hills Capital Partners said he is staying with Leidos Holdings, Inc. LDOS.

Supporting his view, on Tuesday Leidos Holdings reported fourth-quarter fiscal 2024 revenue growth of 10% year-over-year to $4.37 billion, beating the analyst consensus estimate of $4.13 billion. Demand across all customer segments, especially for managed health services, drove the increase.

Don't forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners said AstraZeneca PLC AZN made a strong start to the year.

Adding support to his choice, AstraZeneca, on Feb. 6, reported fourth-quarter earnings and revenue above estimates. Sales of $14.89 billion, up 18% year over year (+19% at constant currency), topped the consensus of $14.29 billion.

Rounding out the trades, Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said with oil above $70, Devon Energy Corporation DVN is wildly profitable.

Supporting her view, Piper Sandler analyst Mark Lear, on Jan. 29, maintained Devon Energy with an Overweight rating and raised the price target from $53 to $54.

Price Action: